Difference between revisions of "Stub"
Line 130: | Line 130: | ||
====Hormonotherapy==== | ====Hormonotherapy==== | ||
*[[Hydrocortisone (Cortef)]] | *[[Hydrocortisone (Cortef)]] | ||
+ | |||
+ | ==PD & Pembrolizumab {{#subobject:06b435|Regimen=1}}== | ||
+ | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
+ | |- | ||
+ | |[[#top|back to top]] | ||
+ | |} | ||
+ | PD & Pembrolizumab: '''<u>P</u>'''omalidomide, '''<u>D</u>'''examethasone, Pembrolizumab | ||
+ | ===Regimen=== | ||
+ | ====Targeted therapy==== | ||
+ | *[[Pomalidomide (Pomalyst)]] | ||
+ | *[[Dexamethasone (Decadron)]] | ||
+ | ====Immunotherapy==== | ||
+ | *[[Pembrolizumab (Keytruda)]] | ||
==Pixantrone & Rituximab== | ==Pixantrone & Rituximab== |
Revision as of 01:22, 10 August 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the Ontology.
Abiraterone & Enzalutamide
back to top |
Regimen
Hormonotherapy
Bortezomib & Bevacizumab
back to top |
Regimen
Targeted therapy
Bortezomib & Siltuximab
back to top |
Regimen
Targeted therapy
CE & Ipilimumab
back to top |
CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab
Regimen
Chemotherapy
Immunotherapy
CE & Thalidomide
back to top |
CE & Thalidomide: Carboplatin, Etoposide, Thalidomide
Regimen
Chemotherapy
Targeted therapy
EP & Ipilimumab
back to top |
EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab
Regimen
Chemotherapy
Immunotherapy
EP, Tamoxifen, RT
back to top |
EP, GM-CSF, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy
Regimen
Chemotherapy
Hormonotherapy
Radiotherapy
- Concurrent thoracic radiation therapy
FULV & Trimetrexate
back to top |
FULV & Trimetrexate: 5-FU & LeucoVorin (Folinic acid), Trimetrexate
Regimen
Chemotherapy
Ixabepilone & Bevacizumab
back to top |
Regimen
Chemotherapy
Targeted therapy
MFL
back to top |
MFL: Methyl-lomustine (MeCCNU), 5-FU & LeucoVorin (Folinic acid)
Regimen
Chemotherapy
Mitoxantrone & Hydrocortisone
back to top |
Regimen
Chemotherapy
Hormonotherapy
PD & Pembrolizumab
back to top |
PD & Pembrolizumab: Pomalidomide, Dexamethasone, Pembrolizumab
Regimen
Targeted therapy
Immunotherapy
Pixantrone & Rituximab
back to top |
Regimen
Chemotherapy
Targeted therapy
TG+Bev
back to top |
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TX+Bev
back to top |
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab
Regimen
Chemotherapy
Targeted therapy
Vinorelbine & Hydrocortisone
back to top |